Encinitas, CA, United States of America

Michael Klein

USPTO Granted Patents = 6 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Michael Klein: A Pioneer in Engineered Polymerases

Introduction: Michael Klein, based in Encinitas, California, is an innovative inventor renowned for his contributions to the field of polymerase engineering. With a total of six patents to his name, Klein has made significant strides in enhancing the functionality of polymerases, which are essential enzymes in various biological applications, including nucleic acid sequencing.

Latest Patents: Klein's recent patents focus on engineered polymerases that demonstrate remarkable attributes. One notable patent features engineered variants of archaeal, prokaryotic, and eukaryotic polymerases that exhibit enhanced thermostability, improved incorporation of 3' modified nucleotides, and better uracil tolerance. These advancements are crucial for polymerase-catalyzed nucleotide extension reactions, making them superior to wild-type polymerase enzymes. Another of his patents details engineered archaeal polymerases with exonuclease-minus activity, which further enhances thermostability and reduces sequence-specific errors in nucleotide binding and extension reactions. These engineered polymerases are also instrumental in forming complexed polymerases and conducting nucleic acid sequencing reactions.

Career Highlights: Throughout his career, Klein has been driven by the pursuit of innovation in biochemical engineering. His role at Element Biosciences, Inc. highlights his commitment to pushing the boundaries of polymerase technology. His inventive work not only adds to the scientific community's understanding of polymerases but also holds promise for various practical applications in genomics and biochemistry.

Collaborations: Klein has collaborated with talented professionals such as Tyler Lopez and Virginia Saade. These partnerships have enabled a synergistic approach to innovation, allowing for the effective development and application of engineered polymerases across diverse research sectors.

Conclusion: Michael Klein's contributions to the field of polymerase engineering underscore his position as a leading inventor. With six patents that enhance the capabilities of polymerases, his work at Element Biosciences, Inc. and collaboration with peers exemplify the value of innovation in scientific advancements. Klein's ongoing research and development efforts are expected to leave a lasting impact on biotechnology and related fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…